Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
1.290
-0.010 (-0.77%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Company Description
Intelligent Bio Solutions Inc., a medical technology company, developing rapid, non-invasive testing, and screening solutions.
The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse.
It also operates biosensor platform for clinical chemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.
The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022.
Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York. The company operates as a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Intelligent Bio Solutions Inc.
| Country | United States |
| Founded | 2016 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 50 |
| CEO | Harry Simeonidis |
Contact Details
Address: 135 West, 41ST Street, 5th Floor New York, New York 10036 United States | |
| Phone | 646 828 8258 |
| Website | ibs.inc |
Stock Details
| Ticker Symbol | INBS |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0001725430 |
| CUSIP Number | 36151G600 |
| ISIN Number | US36151G6008 |
| Employer ID | 82-1512711 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Harry Simeonidis | President and Chief Executive Officer |
| Spiro Kevin Sakiris B.Bus, C.A., CA, Dip Law | Chief Financial Officer |
| Callistus Sequeira | Vice President of Global Quality and Operations |
| Doug Heath | Vice President of Global Sales |
| Anna Turkington | Vice President of Marketing |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 11, 2025 | S-3 | Registration statement under Securities Act of 1933 |
| Apr 1, 2025 | ARS | Filing |
| Apr 1, 2025 | DEF 14A | Other definitive proxy statements |
| Mar 26, 2025 | 8-K | Current Report |
| Mar 25, 2025 | 8-K | Current Report |
| Mar 21, 2025 | 8-K | Current Report |
| Mar 14, 2025 | 8-K | Current Report |
| Mar 12, 2025 | 8-K | Current Report |
| Mar 11, 2025 | 424B5 | Filing |
| Feb 21, 2025 | 8-K | Current Report |